RespireRx Pharmaceuticals Inc (PK) (RSPI) Quote

Crow crows…

I think you may be off a decimal, but needless to say, there has been chunk buys over the past 4 months and lately hardly any dollar volume to speak of. IMO, just a holding pattern until more info is known via 10-k, or some status update on OSA program or the pain/epilepsy tier 3 trials with NIH. I think it is a good sign that BOD memeber loans 100k with only the .0015 warrants to back it up. One would think if there was nothing of significance/value on the horizon, this would be unlikely. Easy accumulate and hold here.

It is interesting looking at other preclinical/IND/phase 1 big pharma deals. Some are anywhere from 10's of million to hundreds of million up front cash with milestone payments possibly well into the hundreds of millions. As the CEO stated if they pass tier 3 preclinicals, they will be open for grant money, but more than likely I would think be striking a similar deal of significance for BP to take the ball and run with it. Such would allow them to focus energy and funds then to one of the other drug platforms they have in the works.

Probably be a fairly boring stock until then I suppose, although as someone mentioned, that seems to be the best case scenario for stocks of this nature. Do nothing, and then strike massive deal, trade for nickels and dimes and more... GLTA.

12:08 est.

6 , purchases of over 100k, less than a million, so in the thousands of dollars...

2 purchases of over a million shares so over ten-thousands of dollars.

Bullish!

Still looking for 10-K filing that is late. However, did see they had an 8-K filing where a BOD member provided a loan, with warrants at .0015. Another example of insiders lining up with equity positions here.

Staying long, she will move eventually. Looking forward to phase 3 news ahead.


$RSPI

Thanks thought it was quite witty...lol.Nice buying today.

We’re getting there sharky. Cmon PENNYLAND

Any thoughts on when we could see any phase 3 news

Ace LoL i love it
RSPI 🟢💚🚀

Nice to see RSPI close up today

$RSPI pipeline: https://respirerx.com/product-pipeline/

For your sake, I hope you are right. Do you truly believe that these guys are not going to keep diluting and then do another RS.

You eating crow.

closer to what?

RSPI getting closer and closer.

Follow the money? While ridicule is usually the best non violent weapon, and bashers use that a lot, Bashers proly want to keep sp low as long as possible so they can weekly or monthly buy more shares until it pops. Einstein did 99 problems on a board but purposely put the wrong answer ladt for which he was soundly taken to rtask by the attending students? His point was one negative out of 99 got more attention than 98 out of 99 correct answers?

The bashers way of expressing negativity strikes me as juvenile at best and most actual juveniles can behave that way a lot of other places and get more attention?

So...they do it in hopes their negativity will keep others from buying until it pops?

Folks trying to bash down the stock?
It is the same one person bashing this stock daily.
What is his motive????
We have a lot of $$$$ invested in this stock and it a shame basher or bashers show up on company that has drugs that may provide hope for so many people. Yes all penny stocks have diluting and yes many of these stock still run hard.
This stock has a history long term history of run hard out of nowhere. I am holding and waiting.

I am still here holding a lot of shares. I got others that have been running so i just leave these idle waiting for the next run.
Other stocks that ran lately were just out of the blue and ran up.

Just buy people. - Jeff

Thanks

Yep.

And for sure there is risk that their candidate drug programs fail at some point in preclinicals; but they genuinely seem enthusiastic and confident given other preclinical efforts and experiences. Considering new VP gets paid at .0015 restricted, recent institutional investor absorbed debt, pushed out to early 2025 and reduced rate to 0%, plus other stakeholders lining up with preferred shares requiring a major payment event to see any ROI at all and then the CEO comments about hoping to open "purse strings" while completing tier 3 NIH preclinicals, hints at where this could be going.

I agree in that when any BP deal is struck, this will be driven by huge money outside IHUB realm, and will be an immediate rocket ship. Given how undervalued the base price is situated, this has that potential to be one stories are told about.

I agree completely....


If there was ever a setup this, is it. Very low volume and PPS at depressed levels (vastly undervalued). I can point to other stocks with much higher (multiples) market caps with a fraction of the potential. All good for me and for the patient. I like getting in on bottoms. This is NOT a IHUB trading stock. This is a big money stock that will be moved by NON IHUB investors. If we haven't already been found with accumulation from weak retail selling, we soon will be imho.

As much as many would not like to hear this. When it is time, THEY WILL DECIDE when it leaves these levels. Honestly the more bashing and whining is a good sign.

Almost ALL of my biggest winners reacted this same way. Under the radar slow accumulation, folks trying to bash down a stock already beaten down to almost silliness levels with minimal volume.

Patience is key!

LMAO as the volume sits at a big fat 0....

I always thought stock message forums were valuable avenues to discuss potential in an investment, what is plausible, where is the risk, deciphering the progress or lack thereof; but wtf do I know.

I personally like the risk v. reward. Risk is of course there is zero progress, the stock flounders at these levels or lower indefinitely. Reward potential is they have preclinical success, strike BP development deals and stock trades at nickels and dimes. Worth my gambling.. er.... speculative money.

Jeff would like to thank you. You are very a important part of the distribution process. -Jeff

IMO, the pharma business in general is a speculation or some would call it a "gamble".. The odds of successfully progressing through development, preclinicals and then Phase 1,2,3 clinicals are low. However, with each successful passing in the various stages of development the value increases,sometimes dramatically. At what point are the bigger pharmas engaged and negotiating development deals, exclusive rights, buyouts? I think the answer is at each and every stage...

Short answer easily found by looking at their filings is that RSPI is the opposite of "sufficiently funded". They need resources to move forward.

I think if their epilepsy/pain drug candidate completes the robust preclinicals of the NIH and is positioned for grant money into human trials, then there is something of very significant value there that big pharma will want in on now before moving into human clinicals. Especially considering the high profile nature of the opioids epidemic.

The OSA program seems to have less risk on the safety aspect of re-purposing dronabinol, moreso on will the new formulations successfully extend the duration of effect while maintaining minimal side effects. Assumption is they are in preclincals there as well with a quicker passage through human trials, less cost to develop. Plus a current estimated valuation around 20 million which nowhere near shows up in the market cap here at the moment.

Amazing to me that some legit IP and legit progress in the pharma world can trade less than a million in valuation while many OTC gambles are sitting at 10x that value with much less prospects or business potential. I think what the gamblers here are seeing is that there is a legit possibility for major BP dealings here that can shoot valuations into the 100's millions similar to past storied pharma stocks. And the potential here would likely have much more sticking power, IMO

GLTA.

Funny to see all the gamblers here... when you are done here, look up GA... never too late

Very possible!!! i would take anything over $1.00 but do believe with this company's pipeline that we could see a buyout offer come in at $4.25, this would set the stage for a rally up to $5.00/ share and then instituitional buyers like Baker Bros Advisors LLC to purchase 15% of the float.


(there is nothing wrong with having Faith in your hopes) :)

Buy Out for $3.00 would be nice:)

Sorry, all. I asked roughly the same thing a while back. Pardon my repetition.

Do not all BP risk losing out to THE BP that buys this all sooner than later in its more speculative status...or is RSPI sufficiently funded and staffed to reject offers until they have an fda approved, analyst recommended, gargantuan?...if anyone knows or cares to speculate?

Exactly.

They have progressed into tier 3 preclinicals with the NIH to mitigate the opioid epidemic. This positive progression is valuable and important. It is only logical that monied interests and big pharma are watching these trials closely. IMO, if these trials confirm their past preclinical observations that lead into human clinicals, than the sky is the limit as to how valuable this drug development program has become.... IMO.

Agreed!

When you least expect it it will pop.

Honestly that's the best way for it to happen. When it is least expected. 👍️

I have been adding some on the dips. Holding tight. Some retail is getting shaken.

Market Cap: 697,214 (Seriously???) LOL

imho worth minimum dirt cheap at 10 million Market Cap.

That is always the case. They are all a POS until they are Not!

They will release Big News when nobody expects it.

I got my popcorn ready for RSPI!

When you least expect it it will pop.Nice buying for an uptick yesterday.

Thank You! I am holding a nice position here, but I want more! LOL I know this one is just a matter of time.

If I can get some more profits on others I will add to my position here.

I’m still here with you as well. I’m holding all the ones that I still think will pop! I’m playing crypto as well, so not as active in the pennies as I normally would be. Best of luck my friend…

Jeff is mad! Come on folks step up and average down. -J

Exactly, thank you for your support. -Jeff

P.S. please don't forget to avg down and help a brotha out.

Not the recent transaction but countless over many years achieving absolutely nothing other than investors loosing money.

Statements like this, again reinforce the level of ignorance on this entire board.
The proceeds from each of the transactions, do not go to the company.
This is not a secondary, or private placement, or IPO etc, etc...
SMH

If its gambling then its a bad bet, always have been always will be imo. But the guys behind the operation continues to live fine of of other people’s money.

This is gambling and not investing.

Looking for...

10-K update to see any tidbits on improving debt/convertibles and restructuring them as they have for other stakeholders already who appear to be lining up with expectations of major progress sooner than later.

The SCI/ADHD is essentially on hold pending funding according to recent PR.

This leaves the OSA program, which hoping to hear an update as to if preclinicals on new formulations are underway, prepping for IND/human clincals???

Any update on tier 3 trials with NIH and "loosening pursestrings". IMO this progress/candidate is legitimately a really big deal and any and all commentary related to the candidate is enthusiastically positive. Obviously no guarantees, but I would have to imagine discussions with big pharma are underway already. With each phase, tier, preclincial... showing positive, the value increases for the IP. Hence, why some here have the opinion that "any day", is the current thesis. GLTA.

I suppose when anyone has so much time equity into a particular stock you are an investor byg default whether your persuasion is more in than out or vice versa.

Still agreeing with you on this one.

"Investors" LOL! - J

Sure there has definitely been some conversions, but all news has been rather vanilla with a passive approach and minimal follow-up. I would think investors would be interested in timelines, next steps/milestones, NIH path and success implications, OSA program updates, funding status/efforts etc, etc.

Although maybe the "short-term loosen purse strings" comment is alluding to their current focus and efforts....

I disagree, Jeff has been increasing the float to the best of his abilities.

I Agree 100%

just feels like this is a really big pharma deal, not simply OTC type of deal...

Considering all the positive traction with their drug candidates, they are not doing a very good job of what you suggest.... if that is the intent...